The Significance of Glucose Turnover in the Brain in the Pathogenetic Mechanisms of Alzheimer's Disease

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Reviews in the Neurosciences

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1515/REVNEURO.1996.7.1.1PMID 8736675
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type

  2005cited by this paper
• Decreased cerebral glucose metabolism associated with mental deterioration in multi-infarct dementia

  2004cited by this paper
• Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid β-protein and tau protein

  2004cited by this paper
• Observations on the brains of demented old people. B.E. Tomlinson, G. Blessed and M. Roth, Journal of the Neurological Sciences (1970) 11, 205–242; (1968) 7, 331–356

  1997cited by this paper
• Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease.

  1995cited by this paper
• Sex differences in regional cerebral glucose metabolism during a resting state

  1995cited by this paper
• Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain.

  1995cited by this paper
• Relationship between lifetime occupation and parietal flow

  1995cited by this paper
• Apolipoprotein E and Alzheimer's disease

  1995cited by this paper
• Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.

  1995cited by this paper
• Asymmetric interictal glucose hypometabolism and cognitive performance in epileptic patients.

  1994cited by this paper
• Alzheimer's disease: therapeutic strategies for the 1990s

  1994cited by this paper
• Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice.

  1994cited by this paper
• Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

  1994cited by this paper
• Rapid decrease in ATP content without recovery phase during glutamate-induced cell death in cultured spinal neurons.

  1994cited by this paper
• Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor.

  1994cited by this paper
• Pathological correlates of dementia in Alzheimer's disease.

  1994cited by this paper
• Future research in Alzheimer's disease using imaging techniques.

  1994cited by this paper
• Age as Risk Factor for Sporadic Dementia of the Alzheimer Type?

  1994cited by this paper
• Dementia in elderly patients: can the 3R mental stimulation programme improve mental status?

  1994cited by this paper
• Ultrastructural analysis of β-amyloid-induced apoptosis in cultured hippocampal neurons

  1994cited by this paper
• What Is Primary and What Secondary for Amyloid Deposition in Alzheimer's Disease

  1994cited by this paper
• Involvement of free oxygen radicals in beta-amyloidosis: an hypothesis.

  1994cited by this paper
• Lack of long-term effects after β-amyloid protein injections in rat brain

  1994cited by this paper
• Free radicals, proteolysis, and the degeneration of neurons in alzheimer disease: How essential is the β-amyloid link?

  1994cited by this paper
• Ultrastructural analysis of beta-amyloid-induced apoptosis in cultured hippocampal neurons.

  1994cited by this paper
• Lack of long-term effects after beta-amyloid protein injections in rat brain.

  1994cited by this paper
• Free radicals, proteolysis, and the degeneration of neurons in Alzheimer disease: how essential is the beta-amyloid link?

  1994cited by this paper
• Beta amyloid neurotoxicity and neuronal degeneration in Alzheimer's disease.

  1994cited by this paper
• Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease.

  1994cited by this paper
• Involvement of free oxygen radicals in β-amyloidosis: An hypothesis

  1994cited by this paper
• Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease

  1994cited by this paper
• Is amyloid causally involved in pathophysiology of Alzheimer's disease?

  1994cited by this paper
• Rapid induction of Alzheimer A beta amyloid formation by zinc.

  1994cited by this paper
• Future research in Alzheimer's disease using imaging techniques

  1994cited by this paper
• How ATP drives proteins across membranes.

  1994cited by this paper
• Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative.

  1994cited by this paper
• Blood-brain barrier in toxic encephalopathies.

  1994cited by this paper
• Energy, oxidative damage, and Alzheimer's disease: clues to the underlying puzzle.

  1994cited by this paper
• Potentially amyloidogenic fragment of 50 kDa and intracellular processing of amyloid precursor protein in cells cultured under leupeptin.

  1994cited by this paper
• Neuronal atrophy, not cell death, is the main hallmark of Alzheimer's disease.

  1994cited by this paper
• A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth

  1994cited by this paper
• The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease.

  1993cited by this paper
• β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease

  1993cited by this paper
• Low blood pressure and blood glucose levels in Alzheimer's disease Evidence for a hypometabolic disorder?

  1993cited by this paper
• The Amyloid Precursor Protein in Ischemic Brain Injury and Chronic Hypoperfusion a

  1993cited by this paper
• beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

  1993cited by this paper
• Age‐Dependent Impairment of Mitochondrial Function in Primate Brain

  1993cited by this paper
• Pathophysiology of the Alzheimer's syndrome

  1993cited by this paper
• Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.

  1993cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Activation PET as an Instrument to Determine Therapeutic Efficacy in Alzheimer's Disease a

  1993cited by this paper
• Abnormalities in Brain Glucose Utilization and Its Impact on Cellular and Molecular Mechanisms in Sporadic Dementia of Alzheimer Type

  1993cited by this paper
• Biologically active domain of the secreted form of the amyloid beta/A4 protein precursor.

  1993cited by this paper
• Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type.

  1993cited by this paper
• beta-Amyloid precursor protein mismetabolism and loss of calcium homeostasis in Alzheimer's disease.

  1993cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• An in vivo study of phosphorus and glucose metabolism in Alzheimer's disease using magnetic resonance spectroscopy and PET.

  1993cited by this paper
• Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth.

  1993cited by this paper
• β‐Amyloid Precursor Protein Mismetabolism and Loss of Calcium Homeostasis in Alzheimer's Disease a

  1993cited by this paper
• Brain protein kinase PK40erk converts TAU into a PHF-like form as found in Alzheimer's disease.

  1993cited by this paper
• Morphological plasticity of synaptic mitochondria during aging.

  1993cited by this paper
• Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments

  1992cited by this paper
• Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells

  1992cited by this paper
• Alzheimer's disease: a cell biological perspective.

  1992cited by this paper
• Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein.

  1992cited by this paper
• Protein folding in the cell

  1992cited by this paper
• ATP mediates fast synaptic transmission in mammalian neurons

  1992cited by this paper
• In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment.

  1992cited by this paper
• Viability of Neocortical Function Shown in Behavioral Activation State PET Studies in Alzheimer Disease

  1992cited by this paper
• Mitochondrial genetics: a paradigm for aging and degenerative diseases?

  1992cited by this paper
• Anterograde and retrograde enhancement of 24-h memory by glucose in elderly humans.

  1992cited by this paper
• Beta-amyloid precursor protein cleavage by a membrane-bound protease.

  1992cited by this paper
• Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor.

  1992cited by this paper
• Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications.

  1992cited by this paper
• In vivo neurotoxicity of beta-amyloid [β(1–40)] and the β(25–35) fragment

  1992cited by this paper
• Glucose and memory in mild senile dementia of the Alzheimer type.

  1992cited by this paper
• Interregional correlations of resting cerebral glucose metabolism in old and young women.

  1992cited by this paper
• Role of Free Radicals in Aging and Disease

  1992cited by this paper
• An Endosomal‐Lysosomal Pathway for Degradation of Amyloid Precursor Protein a

  1992cited by this paper
• The role of amyloid beta-protein in Alzheimer's disease.

  1992cited by this paper
• The Lysosomal System in Neurons

  1992cited by this paper
• Enlargement of synaptic size as a compensative reaction in aging and dementia.

  1992cited by this paper
• The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth.

  1992cited by this paper
• Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat.

  1992cited by this paper
• The lysosomal system in neurons. Involvement at multiple stages of Alzheimer's disease pathogenesis.

  1992cited by this paper
• Normal Processing of the Alzheimer's Disease Amyloid β Protein Precursor Generates Potentially Amyloidogenic Carboxyl‐Terminal Derivatives

  1992cited by this paper
• Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

  1992cited by this paper
• [Cerebral and cardiovascular aging and brain energy metabolism. Studies with positron-emission tomography in man].

  1992cited by this paper
• Cytochrome Oxidase Inhibition: A Novel Animal Model of Alzheimer's Disease

  1992cited by this paper
• Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type.

  1992cited by this paper
• Mitochondrial DNA Mutation Associated with Aging and Degenerative Disease a

  1992cited by this paper
• Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios

  1991cited by this paper
• Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene

  1991cited by this paper
• Brain aging and Alzheimer's disease, "wear and tear" versus "use it or lose it".

  1991cited by this paper
• Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence.

  1991cited by this paper
• Alzheimer plaques and tangles: advances on both fronts

  1991cited by this paper
• Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

  1991cited by this paper
• Mechanisms of Amyloid Deposition in Alzheimer's Disease a

  1991cited by this paper
• Abnormal brain glucose metabolism in Alzheimer's disease, as measured by position emission tomography.

  1991cited by this paper

• A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories

  2024cites this paper
• Mind the Metabolic Gap: Bridging Migraine and Alzheimer's disease through Brain Insulin Resistance

  2024cites this paper
• A SCOPING REVIEW OF ALZHEIMERS DISEASE HYPOTHESES: THE CASE FOR A MULTI-FACTORIAL THEORY

  2023influential citation
• Navigating Alzheimer's Disease via Chronic Stress: the Role of Glucucocorticoids.

  2020cites this paper
• Functions and dysfunctions of nitric oxide in brain.

  2019cites this paper
• Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease

  2018cites this paper
• Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease

  2016cites this paper
• Chronic stress as a risk factor for Alzheimer’s disease

  2014cites this paper
• GAPDH: β-Amyloid Mediated Iron Accumulation in Alzheimer’s Disease: A New Paradigm for Oxidative Stress Induction in Neurodegenerative Disorders

  2013cites this paper
• Protective Effects of Adaptation to Hypoxia in Experimental Alzheimer’s Disease

  2012cites this paper
• Human Ageing and the Growth Hormone/Insulin-Like Growth Factor-I(GH/IGF-I) Axis - The Impact of Growth Factors on Dementia

  2012cites this paper
• Altered Regulation of Akt Signaling with Murine Cerebral Malaria, Effects on Long-Term Neuro-Cognitive Function, Restoration with Lithium Treatment

  2012cites this paper
• Animal Models of Alzheimer's Disease

  2011cites this paper
• Ablation of the Locus Coeruleus Increases Oxidative Stress in Tg-2576 Transgenic but Not Wild-Type Mice

  2010cites this paper
• Importance and prospects for design of selective muscarinic agonists.

  2008cites this paper
• Energy Metabolism in Conformational Diseases

  2008cites this paper
• Insulin Dysfunction Induces In Vivo Tau Hyperphosphorylation through Distinct Mechanisms

  2007cites this paper
• Alterations of Synaptic Turnover Rate in Aging May Trigger Senile Plaque Formation and Neurodegeneration

  2007cites this paper
• Decrease of dehydrogenase activity of cerebral glyceraldehyde-3-phosphate dehydrogenase in different animal models of Alzheimer's disease.

  2007cites this paper
• Nitric Oxide and Nitroxidative Stress in Alzheimer's Disease

  2007cites this paper
• Role of oxidative stress on β-amyloid neurotoxicity elicited during impairment of energy metabolism in the hippocampus: Protection by antioxidants

  2006cites this paper
• On the paradox of ion channel blockade and its benefits in the treatment of Alzheimer disease.

  2005cites this paper
• β-Amyloid (Aβ) causes detachment of N1E-115 neuroblastoma cells by acting as a scaffold for cell-associated plasminogen activation

  2005cites this paper
• Pouring oil into the fire? On the conundrum of the beneficial effects of NMDA receptor antagonists in Alzheimer disease

  2005cites this paper
• The physiology and pathophysiology of nitric oxide in the brain.

  2005cites this paper
• Neuro-modulation, aminergic neuro-disinhibition and neuro-degeneration. Draft of a comprehensive theory for Alzheimer disease.

  2005cites this paper
• Beta-amyloid (Abeta) causes detachment of N1E-115 neuroblastoma cells by acting as a scaffold for cell-associated plasminogen activation.

  2005cites this paper
• Strukturelle, zelluläre und subzelluläre Veränderungen des Gehirns bei physiologischem Altern und der senilen Demenz vom Alzheimer-Typ

  2004cites this paper
• Expansion of the Golgi apparatus in rat cerebral cortex following intracerebroventricular injections of streptozotocin.

  2004cites this paper
• Role of the neocortex in the water maze task in the rat: a detailed behavioral and Golgi-Cox analysis.

  2003cites this paper
• Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: Potential strategies for neuroprotection

  2003cites this paper
• Ethanol‐Induced Decrease of the Expression of Glucose Transport Protein (Glut3) in the Central Nervous System as a Predisposing Condition to Apoptosis

  2003cites this paper
• Subcellular alteration of glyceraldehyde‐3‐phosphate dehydrogenase in Alzheimer's disease fibroblasts

  2003cites this paper
• Vascular Basis of Alzheimer's Pathogenesis

  2002cites this paper
• Vascular basis of Alzheimer's pathogenesis.

  2002cites this paper
• Changes in activity and expression of phosphofructokinase in different rat brain regions after basal forebrain cholinergic lesion

  2002cites this paper
• Alzheimer's β-Amyloid Peptides Compete for Insulin Binding to the Insulin Receptor

  2002cites this paper
• Amyloid beta-peptide 25-35 reduces [3H] acetylcholine release in retinal neurons. Involvement of metabolic dysfunction

  2002cites this paper
• Brain α-endosulfine is manifold decreased in brains from patients with Alzheimer's disease: a tentative marker and drug target?

  2001cites this paper
• Reduction of glyceraldehyde‐3‐phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts

  2001cites this paper
• Critically Attained Threshold of Cerebral Hypoperfusion: Can It Cause Alzheimer's Disease?

  2000cites this paper
• Actions and interactions of the IGF system in Alzheimer's disease: review and hypotheses.

  2000cites this paper
• Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease.

  2000cites this paper
• Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease.

  2000cites this paper
• Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide.

  2000cites this paper
• The metabolism of plasma glucose and catecholamines in Alzheimer's disease.

  2000cites this paper
• A Unifying Hypothesis of Alzheimer's Disease. IV. Causation and Sequence of Events

  2000cites this paper
• Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease.

  2000cites this paper
• Chronic cerebrovascular ischemia in aged rats: effects on brain metabolic capacity and behavior.

  2000cites this paper
• Impaired Cerebromicrovascular Perfusion: Summary of Evidence in Support of Its Causality in Alzheimer's Disease

  2000cites this paper
• Differential display and cloning of the hippocampal gene mRNas in senescence accelerated mouse.

  1999cites this paper
• Cell-Type-Specific Differences in Age-Related Changes of DNA Repair in the Mouse Brain – Molecular Basis for a New Approach to Understand the Selective Neuronal Vulnerability in Alzheimer's Disease

  1999cites this paper
• Critical threshold cerebral hypoperfusion causes Alzheimer’s disease?

  1999cites this paper
• Insulin‐sensitive GLUT4 glucose transporters are colocalized with GLUT3‐expressing cells and demonstrate a chemically distinct neuron‐specific localization in rat brain

  1999cites this paper
• Starvation induces tau hyperphosphorylation in mouse brain: implications for Alzheimer's disease

  1999cites this paper
• Mitochondrial Genome Lesions in the Pathogenesis of Sporadic Alzheimer’s Disease

  1999cites this paper
• Biochemical dysfunction and memory loss: the case of Alzheimer's dementia

  1999cites this paper
• Abnormal Substrate Levels That Depend upon Mitochondrial Function in Cerebrospinal Fluid from Alzheimer Patients

  1998cites this paper
• Glucose metabolism in cholinoceptive cortical ratbrain regions after basal forebrain cholinergic lesion

  1998cites this paper
• Reevaluating the Role of Vascular Changes in the Differential Diagnosis of Alzheimer’s Disease and Vascular Dementia

  1998cites this paper
• Effects of amyloid precursor protein derivatives andoxidative stress on basal forebrain cholinergic systems inALZHEIMERS disease

  1998cites this paper
• Recent developments in the molecular genetics of mitochondrial disorders.

  1998cites this paper
• Catecholamines Potentiate Amyloid β-Peptide Neurotoxicity: Involvement of Oxidative Stress, Mitochondrial Dysfunction, and Perturbed Calcium Homeostasis

  1998cites this paper
• Re-evaluating the role of vascular changes in the differential diagnosis of Alzheimer's disease and vascular dementia.

  1998cites this paper
• Hemodynamic Consequences of Deformed Microvessels in the Brain in Alzheimer's Disease

  1997cites this paper
• Deleterious network: a testable pathogenetic concept of Alzheimer's disease.

  1997cites this paper
• Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease.

  1997cites this paper
• Pathogenesis of Decreased Glucose Turnover and Oxidative Phosphorylation in Ischemic and Trauma‐Induced Dementia of the Alzheimer Type

  1997cites this paper
• Send Orders of Reprints at Reprints@benthamscience.org Human Ageing and the Growth Hormone/insulin-like Growth Factor-i (gh/igf-i) Axis -the Impact of Growth Factors on Dementia §

  year unknowncites this paper